The clinical application potential of extracellular matrix in cardiac tissue engineering

J Thorac Cardiovasc Surg. 2015 Nov;150(5):1290-1. doi: 10.1016/j.jtcvs.2015.08.007. Epub 2015 Aug 7.

Authors

Kay Maeda¹, Marc Ruel²

Affiliations

¹ Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada.
² Division of Cardiac Surgery, University of Ottawa Heart Institute, Ottawa, Ontario, Canada. Electronic address: mruel@ottawaheart.ca.

PMID: 26323619
DOI: 10.1016/j.jtcvs.2015.08.007

No abstract available

Publication types

Editorial
Comment

MeSH terms

Animals
Cardiac Surgical Procedures*
Drug Carriers*
Extracellular Matrix / transplantation*
Female
Fibroblast Growth Factor 2 / administration & dosage*
Heart Ventricles / drug effects*
Heart Ventricles / surgery*
Intestine, Small / transplantation*
Regeneration / drug effects*
Tissue Engineering / methods*
Ventricular Remodeling / drug effects*

Substances

Drug Carriers
Fibroblast Growth Factor 2